Masahiro Shimokawa

Years Active: 2021-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Norifumi Iseda, Shinji Itoh, Katsuya Toshida, Takahiro Tomiyama, Akinari Morinaga, Masahiro Shimokawa, Tomonari Shimagaki, Huanlin Wang, Takeshi Kurihara, Takeo Toshima, Yoshihiro Nagao, Noboru Harada, Tomoharu Yoshizumi, Masaki Mori
Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor-4 inhibition in hepatocellular carcinoma. Cancer science 113 (7) (2022)
Ayano Kabashima, Shu Shimada, Masahiro Shimokawa, Yoshimitsu Akiyama, Minoru Tanabe, Shinji Tanaka
Molecular and immunological paradigms of hepatocellular carcinoma: Special reference to therapeutic approaches. Journal of hepato-biliary-pancreatic sciences 28 (1) (2021)

Masahiro Shimokawa.css-eqlu8i{font-size:small;padding-left:4px;}